Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice
PN Kurlekar, Jagat D Bhatt
Abstract
Open-access reader
PN Kurlekar, Jagat D Bhatt
Abstract
Open-access reader
OBJECTIVE: To study the probable site of the antinociceptive action of fluoxetine and its interaction with morphine and naloxone. MATERIAL AND METHODS: The antinociceptive activity of fluoxetine was studied using tail-flick method in the absence and presence of naloxone in mice. Different doses of fluoxetine (2, 5 and 10 mg/kg) and morphine (0.5 mg/kg and 1 mg/kg) were administered subcutaneously to select the subanalgesic doses for both. Subanalgesic doses of both the drugs were administered simultaneously to study their interaction on tail-flick latency. RESULTS: Fluoxetine and morphine produced a dose-dependent antinociceptive action. Combination of the subanalgesic dose of both fluoxetine (2 mg/kg) and morphine (0.5 mg/kg) produced an additive effect. Naloxone in a dose of 1 mg/kg produced a significant (P<0. 001) hyperalgesia at time intervals of 15, 30 and 60 min while in a dose of 2 mg/kg it produced significant (P<0. 001) hyperalgesia at time intervals of 30, 60 and 120 min. Naloxone (2 mg/kg) pretreatment significantly reduced the antinociception produced by fluoxetine. CONCLUSION: Analgesia produced by fluoxetine may be mediated by 'µ' opioid receptor, however, mechanisms involving other endogenous opioid peptides could not be ruled out. Fluoxetine as a monotherapy or in combination with other opioids could be useful in the management of pain.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To study the probable site of the antinociceptive action of fluoxetine and its interaction with morphine and naloxone. MATERIAL AND METHODS: The antinociceptive activity of fluoxetine was studied using tail-flick method in the absence and presence of naloxone in mice. Different doses of fluoxetine (2, 5 and 10 mg/kg) and morphine (0.5 mg/kg and 1 mg/kg) were administered subcutaneously to select the subanalgesic doses for both. Subanalgesic doses of both the drugs were administered simultaneously to study their interaction on tail-flick latency. RESULTS: Fluoxetine and morphine produced a dose-dependent antinociceptive action. Combination of the subanalgesic dose of both fluoxetine (2 mg/kg) and morphine (0.5 mg/kg) produced an additive effect. Naloxone in a dose of 1 mg/kg produced a significant (P<0. 001) hyperalgesia at time intervals of 15, 30 and 60 min while in a dose of 2 mg/kg it produced significant (P<0. 001) hyperalgesia at time intervals of 30, 60 and 120 min. Naloxone (2 mg/kg) pretreatment significantly reduced the antinociception produced by fluoxetine. CONCLUSION: Analgesia produced by fluoxetine may be mediated by 'µ' opioid receptor, however, mechanisms involving other endogenous opioid peptides could not be ruled out. Fluoxetine as a monotherapy or in combination with other opioids could be useful in the management of pain.
Key concepts: (+)-Naloxone, Fluoxetine, Morphine, Pharmacology, Nociception, Opioid, Hyperalgesia, Chemistry